Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Medipal Holdings Corp?

Accepted Answer

Según el último estado financiero (Form-10K), Medipal Holdings Corp tiene un total de activos de $1,824,984, una ganancia neta profit de $40,279

Question 2

¿Cuáles son los ratios financieros clave para MEPDF?

Accepted Answer

El ratio corriente de Medipal Holdings Corp es 1.51, el margen neto es 1.09, las ventas por acción son $17,609.08.

Question 3

¿Cómo se desglosan los ingresos de Medipal Holdings Corp por segmento o geografía?

Accepted Answer

Medipal Holdings Corp largest revenue segment is Medical Drugs, at a revenue of 2,366,717,000,000 in the most earnings release.For geography, Japan is the primary market for Medipal Holdings Corp, at a revenue of 3,671,328,000,000.

Question 4

¿Es rentable Medipal Holdings Corp?

Accepted Answer

yes, según los últimos estados financieros, Medipal Holdings Corp tiene una ganancia neta profit de $40,279

Question 5

¿Tiene Medipal Holdings Corp alguna deuda?

Accepted Answer

yes, Medipal Holdings Corp tiene una deuda de 1,205,418

Question 6

¿Cuántas acciones en circulación tiene Medipal Holdings Corp?

Accepted Answer

Medipal Holdings Corp tiene un total de acciones en circulación de 207.95

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	3,707,170	3,671,328	3,558,732	3,360,008	3,290,921	3,211,125
Revenue Growth (YoY)	4%	3%	6%	2%	2%	-1%
Cost of Revenue	3,449,332	3,415,569	3,312,077	3,135,703	3,073,476	2,996,912
Gross Profit	257,838	255,759	246,655	224,305	217,445	214,213
Selling, General & Admin	187,939	185,216	184,686	163,040	159,379	162,802
Research & Development	--	1,418	991	103	108	106
Operating Expenses	201,459	200,150	199,325	175,333	171,821	175,637
Other Non Operating Income (Expenses)	10,671	10,845	11,448	9,959	10,246	9,158
Pretax Income	78,033	76,734	74,741	70,061	57,284	49,237
Income Tax Expense	25,897	25,203	22,973	21,738	18,087	15,621
Net Income	40,857	40,279	41,474	38,806	29,423	23,926
Net Income Growth	4%	-3%	7%	32%	23%	-37%
Shares Outstanding (Diluted)	207.62	208.49	211.78	216.34	223.12	223.06
Shares Change (YoY)	-1%	-2%	-2%	-3%	0%	-3%
EPS (Diluted)	196.77	193.19	195.83	179.37	131.86	107.26
EPS Growth	5%	-1%	9%	36%	23%	-35%
Free Cash Flow	--	48,128	48,192	2,642	42,340	18,780
Free Cash Flow Per Share	--	230.84	227.55	12.21	189.76	84.19
Gross Margin	6.95%	6.96%	6.93%	6.67%	6.6%	6.67%
Operating Margin	1.52%	1.51%	1.32%	1.45%	1.38%	1.2%
Profit Margin	1.1%	1.09%	1.16%	1.15%	0.89%	0.74%
Free Cash Flow Margin	--	1.31%	1.35%	0.07%	1.28%	0.58%
EBITDA	69,898	74,026	65,312	63,620	59,962	53,368
EBITDA Margin	1.88%	2.01%	1.83%	1.89%	1.82%	1.66%
D&A For EBITDA	13,519	18,417	17,982	14,648	14,338	14,792
EBIT	56,379	55,609	47,330	48,972	45,624	38,576
EBIT Margin	1.52%	1.51%	1.32%	1.45%	1.38%	1.2%
Effective Tax Rate	33.18%	32.84%	30.73%	31.02%	31.57%	31.72%

Medipal Holdings Corp (MEPDF) Price

MEPDF Stock Price Chart

MEPDF Income

Follow-Up Questions